U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C23H22N2O2
Molecular Weight 358.433
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PB-22

SMILES

CCCCCN1C=C(C(=O)OC2=CC=CC3=CC=CN=C23)C4=C1C=CC=C4

InChI

InChIKey=ZAVGICCEAOUWFM-UHFFFAOYSA-N
InChI=1S/C23H22N2O2/c1-2-3-6-15-25-16-19(18-11-4-5-12-20(18)25)23(26)27-21-13-7-9-17-10-8-14-24-22(17)21/h4-5,7-14,16H,2-3,6,15H2,1H3

HIDE SMILES / InChI

Molecular Formula C23H22N2O2
Molecular Weight 358.433
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/27632803

PB-22, a recreational “designer drugs”, is a cannabimimetic agent, it is a full agonist of cannabinoid receptors. PB-22 has an EC50 of 5.1 nM for human CB1 receptors, and 37 nM for human CB2 receptors. PB-22 produces bradycardia and hypothermia in rats at doses of 0.3–3 mg/kg, suggesting potent cannabinoid-like activity. PB-22 was designated as a Schedule I controlled substance in the United States.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
37.0 nM [EC50]
5.1 nM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

PB-22 produces bradycardia and hypothermia in rats at doses of 0.3–3 mg/kg intraperitoneally
Route of Administration: Intraperitoneal
PB-22 revealed agonistic activity at human CB1 or CB2 receptors (CB1 EC50 = 5.1 nM; CB2 EC50 = 37 nM) in AtT20 neuroblastoma cells, stably transfected with human CB1 or CB2 receptors
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:11:12 GMT 2025
Edited
by admin
on Mon Mar 31 21:11:12 GMT 2025
Record UNII
QM6J8F29FE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PB-22
Code English
DEA NO. 7222
Preferred Name English
J3.283.188E
Code English
PB-22 (CANNABINOID)
Code English
QUPIC
Common Name English
1H-INDOLE-3-CARBOXYLIC ACID, 1-PENTYL-, 8-QUINOLINYL ESTER
Systematic Name English
Classification Tree Code System Code
DEA NO. 7222
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
WIKIPEDIA Designer-drugs-PB-22
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
Code System Code Type Description
CAS
1400742-17-7
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID70856177
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
PRIMARY
FDA UNII
QM6J8F29FE
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
PRIMARY
WIKIPEDIA
PB-22
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
PRIMARY
PUBCHEM
71604304
Created by admin on Mon Mar 31 21:11:12 GMT 2025 , Edited by admin on Mon Mar 31 21:11:12 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Mouse AtT-20 neuroblastoma cells stably transfected with human CB1
EC50
TARGET -> AGONIST
Mouse AtT-20 neuroblastoma cells stably transfected with human CB2
EC50
Related Record Type Details
ACTIVE MOIETY